Strategic Corporate Social Responsibility and Orphan Drug Development: Insights from the US and the EU Biopharmaceutical Industry
Year of publication: |
2013
|
---|---|
Authors: | Bruyaka, Olga ; Zeitzmann, Hanko ; Chalamon, Isabelle ; Wokutch, Richard ; Thakur, Pooja |
Published in: |
Journal of Business Ethics. - Springer, ISSN 0167-4544. - Vol. 117.2013, 1, p. 45-65
|
Publisher: |
Springer |
Subject: | Biopharmaceutical industry | Corporate social responsibility (CSR) | European Union (EU) | Orphan drugs | Rare diseases | Strategic CSR | United States (US) |
-
Bruyaka, Olga, (2013)
-
Lichtenberg, Frank, (2013)
-
Prioritizing treatment of rare diseases: A survey of preferences of Norwegian doctors
Desser, Arna S., (2013)
- More ...
-
Bruyaka, Olga, (2013)
-
Thakur Wernz, Pooja, (2017)
-
Reexamining CEO duality : the surprisingly problematic issues of conceptualization and measurement
Gove, Steve, (2017)
- More ...